Shehata, H. M. et al. Sugar or Fat? Metabolic requirements for immunity to viral infections. Front Immunol. 8, 1311 (2017).
Google Scholar
Stepanova, M., Lam, B., Younossi, Y., Srishord, M. K. & Younossi, Z. M. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. J. Viral Hepat. 19, 341–345 (2012).
Google Scholar
Codo, A. C. et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 32, 437–446 (2020).
Google Scholar
Duette, G. et al. Induction of HIF-1α by HIV-1 infection in CD4+ T cells promotes viral replication and drives extracellular vesicle-mediated inflammation. mBio https://doi.org/10.1128/mBio.00757-18 (2018).
Lahon, A., Arya, R. P. & Banerjea, A. C. Dengue virus dysregulates master transcription factors and PI3K/AKT/mTOR signaling pathway in megakaryocytes. Front. Cell. Infect. Microbiol. 11, 715208 (2021).
Google Scholar
Ajaz, S. et al. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am. J. Physiol. Cell Physiol. 320, C57–C65 (2021).
Google Scholar
Qin, C. et al. SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis. Proc. Natl Acad. Sci. USA 119, e2122897119 (2022).
Google Scholar
Gassen, N. C. et al. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat. Commun. 12, 3818 (2021).
Google Scholar
Palmer, C. S. et al. Increased glucose metabolic activity is associated with CD4+ T cell activation and depletion during chronic HIV infection. AIDS 28, 297–309 (2014).
Palmer, C. S. et al. Glut1 expressing proinflammatory monocytes are elevated in cART-treated and untreated HIV-1+ subjects. J. Immunol. 193, 5595–5603 (2014).
Google Scholar
Valle-Casuso, J. C. et al. Cellular metabolism is a major determinant of HIV-1 reservoir seeding in CD4+ T cells and offers an opportunity to tackle infection. Cell Metab. 29, 611–626 (2019).
Google Scholar
Taylor, H. E. et al. mTOR overcomes multiple metabolic restrictions to enable HIV-1 reverse transcription and intracellular transport. Cell Rep. 31, 107810 (2020).
Google Scholar
Loisel-Meyer, S. et al. Glut1-mediated glucose transport regulates HIV infection. Proc. Natl Acad. Sci. USA 109, 2549–2554 (2012).
Google Scholar
Datta, P. K. et al. Glutamate metabolism in HIV-1-infected macrophages: role of HIV-1 Vpr. Cell Cycle 15, 2288–2298 (2016).
Google Scholar
Palmer, C. S., Cherry, C. L., Sada-Ovalle, I., Singh, A. & Crowe, S. M. Glucose metabolism in T cells and monocytes: new perspectives in HIV pathogenesis. EBioMedicine 6, 31–41 (2016).
Google Scholar
Mullen, P. J. et al. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. Nat. Commun. 12, 1876 (2021).
Google Scholar
Hirabara, S. M. et al. Host cell glutamine metabolism as a potential antiviral target. Clin. Sci. 135, 305–325 (2021).
Google Scholar
Clerc, I. et al. Entry of glucose- and glutamine-derived carbons into the citric acid cycle supports early steps of HIV-1 infection in CD4+ T cells. Nat. Metab. 1, 717–730 (2019).
Sánchez-García, F. J., Pérez-Hernández, C. A., Rodríguez-Murillo, M. & Moreno-Altamirano, M. M. B. The role of tricarboxylic acid cycle metabolites in viral infections. Front Cell. Infect. Microbiol. 11, 725043 (2021).
Google Scholar
Codo, A. C. et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 32, 437–446 (2020).
Google Scholar
Mills, E. L. et al. UCP1 governs liver extracellular succinate and inflammatory pathogenesis. Nat. Metab. 3, 604–617 (2021).
Google Scholar
Menk, A. V. et al. Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions. Cell Rep. 22, 1509–1521 (2018).
Google Scholar
Reina-Campos, M., Scharping, N. E. & Goldrath, A. W. CD8+ T cell metabolism in infection and cancer. Nat. Rev. Immunol. 21, 718–738 (2021).
Kinet, S. et al. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells. Retrovirology 4, 31 (2007).
Manel, N. et al. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115, 449–459 (2003).
Google Scholar
Cheng, J. J. et al. CD36 is a co-receptor for hepatitis C virus E1 protein attachment. Sci. Rep. 6, 21808 (2016).
Google Scholar
Herker, E. et al. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat. Med. 16, 1295–1298 (2010).
Google Scholar
Zhang, J. et al. Epstein–Barr virus-encoded latent membrane protein 1 upregulates glucose transporter 1 transcription via the mTORC1/NF-κB signaling pathways. J. Virol. 91, e02168–16 (2017).
Google Scholar
Thai, M. et al. MYC-induced reprogramming of glutamine catabolism supports optimal virus replication. Nat. Commun. 6, 8873 (2015).
Google Scholar
Chambers, J. W., Maguire, T. G. & Alwine, J. C. Glutamine metabolism is essential for human cytomegalovirus infection. J. Virol. 84, 1867–1873 (2010).
Google Scholar
Yau, C. et al. Dysregulated metabolism underpins Zika-virus-infection-associated impairment in fetal development. Cell Rep. 37, 110118 (2021).
Google Scholar
Oehler, N. et al. Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology 60, 1483–1493 (2014).
Google Scholar
Shimode, S., Nakaoka, R., Shogen, H. & Miyazawa, T. Characterization of feline ASCT1 and ASCT2 as RD-114 virus receptor. J. Gen. Virol. 94, 1608–1612 (2013).
Google Scholar
Tailor, C. S., Nouri, A., Zhao, Y., Takeuchi, Y. & Kabat, D. A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J. Virol. 73, 4470–4474 (1999).
Google Scholar
Lavillette, D. et al. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J. Virol. 76, 6442–6452 (2002).
Google Scholar
Stein, K. R. et al. CD46 facilitates entry and dissemination of human cytomegalovirus. Nat. Commun. 10, 2699 (2019).
Google Scholar
Segerman, A. et al. Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77, 9183–9191 (2003).
Google Scholar
Joubert, P. E. et al. Autophagy induction by the pathogen receptor CD46. Cell Host Microbe 6, 354–366 (2009).
Google Scholar
Kolev, M. et al. Complement regulates nutrient influx and metabolic reprogramming during TH1 cell responses. Immunity 42, 1033–1047 (2015).
Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786–791 (2013).
Google Scholar
Hopfner, K. P. & Hornung, V. Molecular mechanisms and cellular functions of cGAS–STING signalling. Nat. Rev. Mol. Cell Biol. 21, 501–521 (2020).
Google Scholar
Domizio, J. D. et al. The cGAS–STING pathway drives type I IFN immunopathology in COVID-19. Nature 603, 145–151 (2022).
Google Scholar
Imanishi, T. et al. Reciprocal regulation of STING and TCR signaling by mTORC1 for T cell activation and function. Life Sci. Alliance 2, e201800282 (2019).
Google Scholar
Wang, F. et al. S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3. Nat. Immunol. 17, 514–522 (2016).
Google Scholar
Meade, N., King, M., Munger, J. & Walsh, D. mTOR dysregulation by vaccinia virus F17 controls multiple processes with varying roles in infection. J. Virol. 93, e00784–19 (2019).
Google Scholar
Moon, J. S. et al. mTORC1-induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep. 12, 102–115 (2015).
Google Scholar
Lin, H. C. et al. Lactic acid fermentation is required for NLRP3 inflammasome activation. Front. Immunol. 12, 630380 (2021).
Google Scholar
Lu, B. et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670–674 (2012).
Google Scholar
Billingham, L. K. et al. Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. Nat. Immunol. 23, 692–704 (2022).
Google Scholar
Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136–140 (2010).
Google Scholar
Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674–677 (2008).
Google Scholar
Xian, H. et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 54, 1463–1477 (2021).
Google Scholar
Yang, F. et al. Metformin inhibits the NLRP3 inflammasome via AMPK/mTOR-dependent effects in diabetic cardiomyopathy. Int. J. Biol. Sci. 15, 1010–1019 (2019).
Google Scholar
Al-Hashem, F. et al. Metformin inhibits mTOR–HIF-1α axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations. J. Cell. Physiol. 234, 9328–9337 (2019).
Google Scholar
Krall, A. S. et al. Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth. Cell Metab. 33, 1013–1026 (2021).
Google Scholar
Rodrigues, T. S. et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J. Exp. Med. 218, e20201707 (2021).
Google Scholar
Giron, L. B. et al. Plasma markers of disrupted gut permeability in severe COVID-19 patients. Front. Immunol. 12, 686240 (2021).
Google Scholar
Hooftman, A. et al. The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 32, 468–478 (2020).
Google Scholar
Sohail, A. et al. Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. PLoS Pathog. 18, e1010219 (2022).
Google Scholar
Olagnier, D. et al. SARS-CoV-2-mediated suppression of NRF2 signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat. Commun. 11, 4938 (2020).
Google Scholar
Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481–485 (2011).
Google Scholar
Brenner, C. Viral infection as an NAD+ battlefield. Nat. Metab. 4, 2–3 (2022).
Google Scholar
Welsby, I. et al. PARP12, an interferon-stimulated gene involved in the control of protein translation and inflammation. J. Biol. Chem. 289, 26642–26657 (2014).
Google Scholar
Caprara, G. et al. PARP14 controls the nuclear accumulation of a subset of type I IFN-inducible proteins. J. Immunol. 200, 2439–2454 (2018).
Google Scholar
Li, L. et al. ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12. Cell Biosci. 11, 116 (2021).
Google Scholar
Gomes, A. P. et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear–mitochondrial communication during aging. Cell 155, 1624–1638 (2013).
Google Scholar
Zhang, H. et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352, 1436–1443 (2016).
Google Scholar
Clement, J., Wong, M., Poljak, A., Sachdev, P. & Braidy, N. The plasma NAD+ metabolome is dysregulated in ‘normal’ aging. Rejuvenation Res. 22, 121–130 (2019).
Google Scholar
Xiao, N. et al. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat. Commun. 12, 1618 (2021).
Google Scholar
Wang, F. et al. Interferon gamma induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and proinflammatory activity. EBioMedicine 30, 303–316 (2018).
Google Scholar
Vigo, T. et al. IFN-β enhances mesenchymal stromal (stem) cells immunomodulatory function through STAT1–3 activation and mTOR-associated promotion of glucose metabolism. Cell Death Dis. 10, 85 (2019).
Google Scholar
Chan, C. C. et al. Type I interferon sensing unlocks dormant adipocyte inflammatory potential. Nat. Commun. 11, 2745 (2020).
Google Scholar
Aliyari, S. R. et al. Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2. Acta Pharm. Sin. B https://doi.org/10.1016/j.apsb.2022.02.019 (2022).
Lercher, A. et al. Type I interferon signaling disrupts the hepatic urea cycle and alters systemic metabolism to suppress T cell function. Immunity 51, 1074–1087 (2019).
Google Scholar
Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013).
Google Scholar
Mills, E. L. et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167, 457–470 (2016).
Google Scholar
Lampropoulou, V. et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24, 158–166 (2016).
Google Scholar
Bambouskova, M. et al. Itaconate confers tolerance to late NLRP3 inflammasome activation. Cell Rep. 34, 108756 (2021).
Google Scholar
Regard, J. B., Sato, I. T. & Coughlin, S. R. Anatomical profiling of G-protein-coupled receptor expression. Cell 135, 561–571 (2008).
Google Scholar
Ghosh, S. & Marsh, E. N. G. Viperin: an ancient radical SAM enzyme finds its place in modern cellular metabolism and innate immunity. J. Biol. Chem. 295, 11513–11528 (2020).
Google Scholar
Gizzi, A. S. et al. A naturally occurring antiviral ribonucleotide encoded by the human genome. Nature 558, 610–614 (2018).
Google Scholar
Honarmand Ebrahimi, K., Vowles, J., Browne, C., McCullagh, J. & James, W. S. ddhCTP produced by the radical-SAM activity of RSAD2 (viperin) inhibits the NAD+-dependent activity of enzymes to modulate metabolism. FEBS Lett. 594, 1631–1644 (2020).
Google Scholar
Britt, E. C. et al. Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils. Nat. Metab. 4, 389–403 (2022).
Google Scholar
Kishimoto, N. et al. Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration. Retrovirology 17, 31 (2020).
Google Scholar
Chang, C. H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239–1251 (2013).
Google Scholar
Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113–117 (2018).
Google Scholar
Diskin, C. et al. 4-octyl-itaconate and dimethyl fumarate inhibit COX2 expression and prostaglandin production in macrophages. J. Immunol. 207, 2561–2569 (2021).
Google Scholar
Murray, L. A., Sheng, X. & Cristea, I. M. Orchestration of protein acetylation as a toggle for cellular defense and virus replication. Nat. Commun. 9, 4967 (2018).
Google Scholar
Guillon, A. et al. Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein. EMBO J. 41, e108306 (2022).
Google Scholar
Ashbrook, M. J. et al. Citrate modulates lipopolysaccharide-induced monocyte inflammatory responses. Clin. Exp. Immunol. 180, 520–530 (2015).
Google Scholar
Williams, N. C. & O’Neill, L. A. J. A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation. Front. Immunol. 9, 141 (2018).
Google Scholar
Cappel, D. A. et al. Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver. Cell Metab. 29, 1291–1305 (2019).
Google Scholar
Vastag, L., Koyuncu, E., Grady, S. L., Shenk, T. E. & Rabinowitz, J. D. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 7, e1002124 (2011).
Google Scholar
Zhou, L. et al. Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition. Nat. Commun. 12, 98 (2021).
Google Scholar
Hicks, K. G. et al. Protein-metabolite interactomics reveals novel regulation of carbohydrate metabolism. Preprint at bioRxiv https://doi.org/10.1101/2021.08.28.458030 (2021).
Garcia-Cazorla, A. et al. Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann. Neurol. 59, 121–127 (2006).
Google Scholar
Taylor, H. E. et al. Phospholipase D1 couples CD4+ T cell activation to c-Myc-dependent deoxyribonucleotide pool expansion and HIV-1 replication. PLoS Pathog. 11, e1004864 (2015).
Google Scholar
Taylor, H. E. & Palmer, C. S. CD4+ T cell metabolism is a major contributor of HIV infectivity and reservoir persistence. Immunometabolism 2, e200005 (2020).
Singh, S. et al. Antioxidant nanozyme counteracts HIV-1 by modulating intracellular redox potential. EMBO Mol. Med. 13, e13314 (2021).
Google Scholar
Shytaj, I. L. et al. Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress. EMBO Mol. Med. 13, e13901 (2021).
Google Scholar
Kishimoto, N. et al. Glucose-dependent aerobic glycolysis contributes to recruiting viral components into HIV-1 particles to maintain infectivity. Biochem. Biophys. Res. Commun. 549, 187–193 (2021).
Google Scholar
Guo, H. et al. Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication. Nat. Immunol. 22, 423–433 (2021).
Google Scholar
Valle-Casuso, J. C. et al. Cellular metabolism is a major determinant of HIV-1 reservoir seeding in CD4+ T cells and offers an opportunity to tackle infection. Cell Metab. https://doi.org/10.1016/j.cmet.2018.11.015 (2018).
Hegedus, A. et al. Evidence for altered glutamine metabolism in human immunodeficiency virus type 1 infected primary human CD4+ T cells. AIDS Res. Hum. Retroviruses 33, 1236–1247 (2017).
Google Scholar
Kulkarni, M. M. et al. Cellular fatty acid synthase is required for late stages of HIV-1 replication. Retrovirology 14, 45 (2017).
Google Scholar
Palmer, C. S., Palchaudhuri, R., Albargy, H., Abdel-Mohsen, M. & Crowe, S. M. Exploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammaging. F1000Research 7, 125 (2018).
Google Scholar
Couturier, J. et al. Lymphocytes upregulate CD36 in adipose tissue and liver. Adipocyte 8, 154–163 (2019).
Google Scholar
Surendar, J. et al. Adiponectin limits IFN-γ- and IL-17-producing CD4+ T cells in obesity by restraining cell-intrinsic glycolysis. Front Immunol. 10, 2555 (2019).
Google Scholar
Angin, M. et al. Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection. Nat. Metab. 1, 704–716 (2019).
Google Scholar
Alrubayyi, A. et al. Functional restoration of exhausted CD8+ T cells in chronic HIV-1 infection by targeting mitochondrial dysfunction. Front Immunol. 13, 908697 (2022).
Ellery, P. J. et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178, 6581–6589 (2007).
Barrero, C. A. et al. HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS ONE 8, e68376 (2013).
Google Scholar
Godfrey, C. et al. Obesity and fat metabolism in human immunodeficiency virus-infected individuals: immunopathogenic mechanisms and clinical implications. J. Infect. Dis. 220, 420–431 (2019).
Google Scholar
Aounallah, M. et al. Current topics in HIV pathogenesis, part 2: Inflammation drives a Warburg-like effect on the metabolism of HIV-infected subjects. Cytokine Growth Factor Rev. 28, 1–10 (2016).
Google Scholar
Butterfield, T. R., Landay, A. L. & Anzinger, J. J. Dysfunctional immunometabolism in HIV infection: contributing factors and implications for age-related comorbid diseases. Curr. HIV/AIDS Rep. 17, 125–137 (2020).
Google Scholar
Anzinger, J. J. et al. Glut1 expression level on inflammatory monocytes is associated with markers of cardiovascular disease risk in HIV-infected individuals. J. Acquir. Immune Defic. Syndr. 77, e28–e30 (2018).
Google Scholar
Butterfield, T. R. et al. Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease. AIDS 31, 199–205 (2017).
Google Scholar
Butterfield, T. R. et al. Elevated CD4+ T cell glucose metabolism in HIV+ women with diabetes mellitus. AIDS https://doi.org/10.1097/qad.0000000000003272 (2022).
Maisa, A. et al. Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration. AIDS 29, 1445–1457 (2015).
Google Scholar
Alzahrani, J. et al. Inflammatory and immunometabolic consequences of gut dysfunction in HIV: parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities. EBioMedicine 46, 522–531 (2019).
Google Scholar
Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575–580 (2019).
Google Scholar
Pan, R. Y. et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer’s disease. Cell Metab. 34, 634–648 (2022).
Google Scholar
Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408–415 (2011).
Google Scholar
Gorwood, J. et al. The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human/simian adipose tissue and human adipocytes. Clin. Infect. Dis. 71, e549–e560 (2020).
Google Scholar
Bastard, J. P. et al. Altered subcutaneous adipose tissue parameters after switching ART-controlled HIV+ patients to raltegravir/maraviroc. AIDS 35, 1625–1630 (2021).
Google Scholar
Heer, C. D. et al. Coronavirus infection and PARP expression dysregulate the NAD metabolome: an actionable component of innate immunity. J. Biol. Chem. 295, 17986–17996 (2020).
Google Scholar
Cohen, M. S. Interplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family. Genes Dev. 34, 254–262 (2020).
Google Scholar
Stefan, N., Birkenfeld, A. L. & Schulze, M. B. Global pandemics interconnected—obesity, impaired metabolic health and COVID-19. Nat. Rev. Endocrinol. 17, 135–149 (2021).
Google Scholar
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 (2020).
Google Scholar
Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3–20 (2022).
Google Scholar
Wang, L. et al. Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells. EBioMedicine 43, 525–536 (2019).
Google Scholar
Cao, Y. et al. Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Res. 68, 8667–8672 (2008).
Google Scholar
Banerjee, S. et al. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1–PI3K axis. Biochemistry 47, 3345–3351 (2008).
Google Scholar
Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856–860 (2020).
Google Scholar
Wu, C. T. et al. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metab. 33, 1565–1576 (2021).
Google Scholar
Qadir, M. M. F. et al. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes. JCI Insight 6, e151551 (2021).
Google Scholar
Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881–895 (2022).
Google Scholar
Müller, J. A. et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat. Metab. 3, 149–165 (2021).
Google Scholar
Montefusco, L. et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 3, 774–785 (2021).
Google Scholar
Mittal, J. et al. High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: a case–control study. Diabetes Metab. Syndr. 15, 102302 (2021).
Google Scholar
Wanner, N. et al. Molecular consequences of SARS-CoV-2 liver tropism. Nat. Metab. 4, 310–319 (2022).
Google Scholar
Wei, C. et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab. 2, 1391–1400 (2020).
Google Scholar
Barnes, E. Infection of liver hepatocytes with SARS-CoV-2. Nat. Metab. 4, 301–302 (2022).
Google Scholar
Delorey, T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107–113 (2021).
Google Scholar
Reiterer, M. et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 33, 2174–2188 (2021).
Google Scholar
Olivo, A. et al. Detection of SARS-CoV-2 in subcutaneous fat but not visceral fat, and the disruption of fat lymphocyte homeostasis in both fat tissues in the macaque. Commun. Biol. 5, 542 (2022).
Google Scholar
Obukhov, A. G. et al. SARS-CoV-2 infections and ACE2: clinical outcomes linked with increased morbidity and mortality in individuals with diabetes. Diabetes 69, 1875–1886 (2020).
Google Scholar
Qeadan, F. et al. The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: a nationwide cohort from the US using the Cerner Real-World Data. PLoS ONE 17, e0266809 (2022).
Google Scholar
Laurenzi, A. et al. No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection. J. Clin. Endocrinol. Metab. 107, e1009–e1019 (2022).
Google Scholar
Wang, W. et al. Elevated glucose level leads to rapid COVID-19 progression and high fatality. BMC Pulm. Med. 21, 64 (2021).
Google Scholar
Wu, J. et al. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study. BMJ Open Diabetes Res. Care 8, e001476 (2020).
Google Scholar
Wan, L. et al. GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia. Nat. Metab. 4, 29–43 (2022).
Google Scholar
Chu, J. et al. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication. Nat. Metab. 3, 1466–1475 (2021).
Google Scholar
Wu, Z. et al. Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity. Signal Transduct. Target Ther. 6, 231 (2021).
Google Scholar
Scherer, P. E., Kirwan, J. P. & Rosen, C. J. Post-acute sequelae of COVID-19: a metabolic perspective. eLife 11, e78200 (2022).
Google Scholar
Zankharia, U., Yadav, A., Yi, Y., Hahn, B. H. & Collman, R. G. Highly restricted SARS-CoV-2 receptor expression and resistance to infection by primary human monocytes and monocyte-derived macrophages. J. Leukoc. Biol. 112, 569–576 (2022).
Google Scholar
Junqueira, C. et al. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606, 576–584 (2022).
Google Scholar
Lee, J. W. et al. Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nat. Biotechnol. 40, 110–120 (2022).
Google Scholar
Zhu, L. et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 31, 1068–1077 (2020).
Google Scholar
Tong, L. et al. A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2. Nat. Metab. 4, 547–558 (2022).
Google Scholar
Proal, A. D. & VanElzakker, M. B. Pathogens hijack host cell metabolism: intracellular infection as a driver of the warburg effect in cancer and other chronic inflammatory conditions. Immunometabolism 3, e210003 (2021).
Google Scholar
Prusinkiewicz, M. A. & Mymryk, J. S. Metabolic reprogramming of the host cell by human adenovirus infection. Viruses 11, 141 (2019).
Google Scholar
Foo, J., Bellot, G., Pervaiz, S. & Alonso, S. Mitochondria-mediated oxidative stress during viral infection. Trends Microbiol. 30, 679–692 (2022).
Google Scholar
Blais, E. M. et al. Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions. Nat. Commun. 8, 14250 (2017).
Google Scholar
Fuller, K. N. Z. & Thyfault, J. P. Barriers in translating preclinical rodent exercise metabolism findings to human health. J. Appl Physiol. 130, 182–192 (2021).
Google Scholar
Omarjee, L. et al. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19. Aging 12, 26263–26278 (2020).
Google Scholar
Quinn, K. M., Palchaudhuri, R., Palmer, C. S. & La Gruta, N. L. The clock is ticking: the impact of ageing on T cell metabolism. Clin. Transl. Immunol. 8, e01091 (2019).
Google Scholar
Guillot-Sestier, M. V. et al. Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer’s disease. Commun. Biol. 4, 711 (2021).
Google Scholar
Auer, M. K. et al. 12-months metabolic changes among gender dysphoric individuals under cross-sex hormone treatment: a targeted metabolomics study. Sci. Rep. 6, 37005 (2016).
Google Scholar
Manuel, R. S. J. & Liang, Y. Sexual dimorphism in immunometabolism and autoimmunity: impact on personalized medicine. Autoimmun. Rev. 20, 102775 (2021).
Google Scholar
van Valkengoed, I. G. M. et al. Ethnic differences in metabolite signatures and type 2 diabetes: a nested case–control analysis among people of South Asian, African and European origin. Nutr. Diabetes 7, 300 (2017).
Google Scholar
Palmer, C., Hampartzoumian, T., Lloyd, A. & Zekry, A. A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection. Hepatology 48, 374–384 (2008).
Google Scholar
Palmer, C. et al. The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection. Gut 59, 397–404 (2010).
Google Scholar
Bressler, B. L., Guindi, M., Tomlinson, G. & Heathcote, J. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology 38, 639–644 (2003).
Google Scholar
Maier, H. E. et al. Obesity is associated with increased susceptibility to influenza a (H1N1pdm) but Not H3N2 Infection. Clin. Infect. Dis. 73, e4345–e4352 (2021).
Google Scholar
Tanes, C. et al. Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. Cell Host Microbe 29, 394–407 (2021).
Google Scholar
Gacesa, R. et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732–739 (2022).
Google Scholar
Hurst, J. H. et al. Age-related changes in the nasopharyngeal microbiome are associated with SARS-CoV-2 infection and symptoms among children, adolescents and young adults. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciac184 (2022).
Chen, Y. et al. Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM. Microbiome 9, 237 (2021).
Google Scholar
Palmer, C. S. et al. Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection. FEBS Lett. 591, 3319–3332 (2017).
Google Scholar
Giron, L. B. et al. Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat. Commun. 12, 3922 (2021).
Google Scholar
Varco-Merth, B. D. et al. Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy. J. Clin. Invest. https://doi.org/10.1172/jci156063 (2022).
Palmer, C. S. et al. Emerging role and characterization of immunometabolism: relevance to HIV pathogenesis, serious non-AIDS events, and a cure. J. Immunol. 196, 4437–4444 (2016).
Google Scholar
Netti, G. S. et al. mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients. Am. J. Transpl. 22, 1475–1482 (2022).
Google Scholar
Garcia-Mesa, Y. et al. Dimethyl fumarate, an approved multiple sclerosis treatment, reduces brain oxidative stress in SIV-infected rhesus macaques: potential therapeutic repurposing for HIV neuroprotection. Antioxidants 10, 416 (2021).
Google Scholar
Hitakarun, A. et al. Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus. Sci. Rep. 10, 1499 (2020).
Google Scholar
Caputo, A., Guzman, C. A., Palmer, C. S. & Nicoli, F. Editorial: the role of systemic and cellular metabolism on susceptibility to infections and responsiveness to vaccination. Front. Cell. Infect. Microbiol. 12, 854241 (2022).
Google Scholar
Hileman, C. O. et al. Plasma citrate and succinate are associated with neurocognitive impairment in older people with HIV. Clin. Infect. Dis. 73, e765–e772 (2021).
Google Scholar
Yeoh, H. L. et al. Immunometabolic and lipidomic markers associated with the frailty index and quality of life in aging HIV+ men on antiretroviral therapy. EBioMedicine 22, 112–121 (2017).
Google Scholar
Giron, L. B. et al. Phospholipid metabolism is associated with time to HIV rebound upon treatment interruption. mBio 12, e03444–20 (2021).
Google Scholar
Tarancon-Diez, L. et al. Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection. EBioMedicine 42, 86–96 (2019).
Google Scholar
Ahl, P. J. et al. Met-Flow, a strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations. Commun. Biol. 3, 305 (2020).
Google Scholar
Masson, J. J. R. et al. The multiparametric analysis of mitochondrial dynamics in T cells from cryopreserved peripheral blood mononuclear cells. Methods Mol. Biol. 2184, 215–224 (2020).
Google Scholar
Carbone, F. et al. Metabolomics, lipidomics and immunometabolism. Methods Mol. Biol. 2285, 319–328 (2021).
Google Scholar
Purohit, V., Wagner, A., Yosef, N. & Kuchroo, V. K. Systems-based approaches to study immunometabolism. Cell Mol. Immunol. 19, 409–420 (2022).
Google Scholar
Weinstock, A. et al. Single-cell RNA sequencing of visceral adipose tissue leukocytes reveals that caloric restriction following obesity promotes the accumulation of a distinct macrophage population with features of phagocytic cells. Immunometabolism 1, e190008 (2019).
Google Scholar
Goldberg, E. L. et al. Ketogenesis activates metabolically protective γδ T cells in visceral adipose tissue. Nat. Metab. 2, 50–61 (2020).
Google Scholar
Levine, L. S. et al. Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response. Immunity 54, 829–844 (2021).
Google Scholar
Verberk, S. G. S. et al. An integrated toolbox to profile macrophage immunometabolism. Cell Rep. Methods 2, 100192 (2022).
Google Scholar
Argüello, R. J. et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metab. 32, 1063–1075 (2020).
Google Scholar
Source: news.google.com